Division of Behavioral Genetics, Department of Psychiatry and Human Behavior, Warren Alpert School of Medicine, Brown University, Providence, RI 02903, USA.
Pharmacol Biochem Behav. 2011 Aug;99(2):262-74. doi: 10.1016/j.pbb.2011.05.002. Epub 2011 May 10.
Attention-deficit hyperactivity disorder (ADHD) is associated with multiple cognition-related phenotypic features in both children and adults. This review aims to clarify the role of cognition in ADHD and how prevailing treatments, which are often highly effective at reducing the clinical symptoms of the disorder, fare in modulating ADHD-related cognitive processes. First, we consider how the broad construct of cognition can be conceptualized in the context of ADHD. Second, we review the available evidence for how a range of both pharmacological and non-pharmacological interventions have fared with respect to enhancing cognition in individuals affected by this pervasive disorder. Findings from the literature suggest that the effects across a broad range of pharmacological and non-pharmacological interventions on the characteristic symptoms of ADHD can be distinguished from their effects on cognitive impairments. As such the direct clinical relevance of cognition enhancing effects of different interventions is somewhat limited. Recommendations for future research are discussed, including the identification of cognition-related endophenotypes, the refinement of the ADHD clinical phenotype, and studying the difference between acute and chronic treatment regimens.
注意缺陷多动障碍(ADHD)与儿童和成人的多种与认知相关的表型特征有关。本综述旨在阐明认知在 ADHD 中的作用,以及目前常用的治疗方法在调节与 ADHD 相关的认知过程方面的效果如何。首先,我们考虑了在 ADHD 背景下如何对认知这一广泛的结构进行概念化。其次,我们回顾了一系列药理学和非药理学干预措施在增强受这种普遍障碍影响的个体的认知方面的效果。文献中的研究结果表明,广泛的药理学和非药理学干预措施对 ADHD 的典型症状的影响可以与对认知障碍的影响区分开来。因此,不同干预措施对认知的增强作用的直接临床相关性有些有限。讨论了对未来研究的建议,包括识别与认知相关的内表型、细化 ADHD 的临床表型,以及研究急性和慢性治疗方案之间的差异。